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   Influence of sodium pentobarbital anesthesia on the adrenal ascorbic 
acid response to various stimuli (morphine, histamine, adrenaline and insu-
lin) was investigated. Sodium pentobarbital inhibited a fall in adrenal 
ascorbic acid concentration induced by morphine, whereas it was ineffective 
in inhibiting adrenal ascorbic acid depletion induced by adrenaline, hist-
amine and insulin.
   In a previous study it was shown that sodium pentobarbital anesthesia did not 
induce any reduction of adrenal ascorbic acid concentration in rats. 3 > HARWOOD and 
MASON 2~ found that the 17-hydroxycorticosteroid level of peripheral blood in monkeys 
was depressed by the administration of sodium pentobarbital, while an elevation of 
this level was induced by the administration of tranquilizing drugs, such as reserpine 
and chlorpromazine. 
   Moreover, the adrenal ascorbic acid depletion produced by morphine in unanesthe-
tized rats was not observed in rats anesthetized with sodium pentobarbital.1)4) 
   In view of this it would seem to be of interest to know how sodium pentobarbital 
anesthesia affects the adrenal ascorbic acid depletion producible by various stressful stimu-
li other than morphine. The present study was an attempt to elucidate this problem.
METHODS
   Male adult rats of an inbred strain, previously accustomed to injection by injec-
ting saline solution twice daily for a week, were used in experiments. 
   In each series of experiments four groups of rats were used. The first and the 
third groups were injected with saline solution and the second and the fourth groups 
were treated with sodium pentobarbital. One hour after injection stressful stimuli 
were given in the third and the fourth groups. Two hours after the injection of 
saline solution or sodium pentobarbital, the animals were killed by a blow on the head 
and both adrenals were quickly removed. Adrenal ascorbic acid concentration was 
determined by the method of ROE and KUETHER5 and was expressed as mg per 100 
g fresh adrenal. 
   Sodium pentobarbital (Nembutal, Abbott) was administered subcutaneously in a 
dose of 5 mg per 100 g body weight. The agents used as stressful stimuli were ; 
morphine, histamine, adrenaline and insulin. Each of the above drugs was dissolved 
in 0.2 cc saline solution per 100 g body weight.
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                         RESULTS 
    There was no significant difference between adrenal ascorbic acid concentrations 
of rats injected with saline (group 1) and those anesthetized with sodium pentobarbi-
tal (group 2). Thus, the experimental results of BRIGGS and MUNSON') and of 
MITAMURA3 ) were confirmed.
Morphine 
   Morphine hydrochloride in a dose of 2 mg per 100 g body weight was injected 
subcutaneously. 
   The results are presented in Table 1. Morphine administration induced a reduc-
tion in adrenal ascorbic acid concentration of rats previously treated with saline injec-
tion. Pretreatment with sodium pentobarbital on the other hand was proved to block 
the effect of morphine.
                     TABLE 1. 
Effect of Sodium Pentobarbital on Adrenal Ascorbic Acid Depletion 
Induced by Morphine
                                        Adrenal ascorbic 
          No. of acid conc. Group 
rats Treatment (mg/100 g) P 
                                              Mean f S. E.* 
   1 7 Saline 453 +_ 8.7
  2 7 Sodium pentobarbital 458 t 9.1 >0.70 (compared with 
  3 7 Saline, Morphine 357 +_ 6.6 group 1) 
  4 7 Sodium pentobarbital, 458 +_ 7.9 <0.001 (compared with                        Morphine 
                                                                  group 3)
Standard error of the mean
Histamine 
   Histamine dihydrochloride (0.5 mg per 100 g body weight) was injected intrape-
ritoneally. 
    The results are summarized in Table 2. In unanesthetized rats a significant 
decrease in adrenal ascorbic acid was induced by the administration of histamine. In 
rats anesthetized with sodium pentobarbital almost the same adrenal ascorbic acid 
response to histamine as in unanesthetized rats was observed.
                     TABLE 2. 
Effect of Sodium Pentobarbital on Adrenal Ascorbic Acid Depletion 
IncJuced by Histamine
                                        Adrenal ascorbic 
Group No. of Treatment acid conc. P          rats (mg/100 g) 
                                              Mean +_ S. E.
  1 6 Saline 469 ± 11.2
  2 6 Sodium pentobarbital 447 ± 10.0 >0.10 (compared with 
  3 10 Saline, Histamine 243 ± 6.3 group 1) 
  4 10 Sodium pentobarbital, 246 ± 7.7 >0,70 (compared with                         His amine 
                                                                 group 3)
Adrenaline 
   L-adrenaline hydrochloride (0.05 mg per 100 g body weight) was injected subcu-
taneously. 
   The results are epitomized in Table 3. A reduction in adrenal ascorbic acid 
concentration was produced by adrenaline injection in rats anesthetized with sodium 
pentobarbital as well as in unanesthetized rats.
                     TABLE 3. 
Effect of Sodium Pentobarbital on Adrenal Ascorbic Acid Depletion 
Induced by Adrenaline
                                        Adrenal ascorbic 
Group No. of Treatment acid conc. P         rats (mg/100 g) 
                                        Mean ± S. E. 
  1 7 Saline 446 ± 8.4
  2 7 Sodium pentobarbital 433 f 8.9 >0.30 (compared with 
  3 10 Saline, Adrenaline 296 +_ 7.7 group 1) 
  4 10 Sodium pentobarbital, 308 +_ 7.6 >0.30 (compared with                        Adrenaline 
                                                                 group 3)
   The difference between the adrenal ascorbic acid concentrations in the two 
groups was not statistically significant. Thus, sodium pentobarbital anesthesia was 
shown to be ineffective in inhibiting the adrenal ascorbic acid depletion producible by 
adrenaline. 
Insulin 
   Insulin (0.2 U per 100 g body weight) was injected subcutaneously. 
   The results are shown in Table 4. The adrenal ascorbic acid depletion produced 
by insulin injection in rats anesthetized with sodium pentobarbital was of the same 
order of magnitude as that of unanesthetized rats. Thus sodium pentobarbital anes-
thesia was found to be ineffective in suppressing the adrenal ascorbic acid response to 
insulin.
                    TABLE 4. 
Effect of Sodium Pentobarbital on Adrenal Ascorbic Acid Depletion 
Induced by Insulin
                                       Adrenal ascorbic 
Group No. of Treatment acid conc. P         rats (mg/100 g) 
                                        Mean t S. E. 
  1 5 Saline 437 ± 8.2
  2 5 Sodium pentobarbital 444 + 9.6 >0.60 (compared with 
  3 9 Saline, Insulin 293 ± 9.2 group 1) 
  4 9 Sodium pentobarbital, 317 ± 10.6 >0.10 (compared with                        Insulin 
group 3)
                    DISCUSSION 
The observations of BRIGGS and MUNSON') and OHLER and SEVY2) that the
adrenal ascorbic acid depletion produced by morphine administration is inhibited by 
pretreatment of sodium pentobarbital are confirmed by the present study. 
   It is also shown by the present investigation that sodium pentobarbital anesthesia 
is not capable of inhibiting the effects of histamine, adrenaline and insulin on the 
pituitary-adrenal system. On the other hand, it has been reported by BRIGGS and 
MUNSON" that the effects of histamine and adrenaline on the pituitary-adrenal system 
are inhibited by pretreatment with morphine. These data tend to indicate that sodium 
pentobarbital and morphine suppress the responsiveness of the pituitary-adrenal system 
to stressful stimuli by acting at different loci along the neural or neuro-humoral path-
way subserving ACTH secretion of the anterior pituitary. 
    ACKNOWLEDGMENT. I am grateful to Prof. T. Suzuki for his interest and help.
REFERENCES
1) BRTGGS, F. N. AND MUNSON, P. L. : Endocrinology 57 : 205 (1955). 
2) HARWOOD, C. T. AND MASON, J. W. : ibid. 60 : 239 (1957), 
3) MTTAMURA, T . : Acta med, nagasaki. 5 : 58 (1960) 
4) OHLER, E. A, AND SEVY, R. W. Endocrinology 59 : 347 (1956). 
5) RoE, J. H. AND KUETHER, C. A. : J. Biol. Chem. 147: 399 (1943).
